184 related articles for article (PubMed ID: 25535613)
1. Levels of soluble E-cadherin in breast, gastric, and colorectal cancers.
Repetto O; De Paoli P; De Re V; Canzonieri V; Cannizzaro R
Biomed Res Int; 2014; 2014():408047. PubMed ID: 25535613
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between serum levels of E- and P-cadherin fragments and the presence of breast cancer.
Knudsen KA; Lin CY; Johnson KR; Wheelock MJ; Keshgegian AA; Soler AP
Hum Pathol; 2000 Aug; 31(8):961-5. PubMed ID: 10987257
[TBL] [Abstract][Full Text] [Related]
4. Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis.
Mărgineanu E; Cotrutz CE; Cotrutz C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):432-6. PubMed ID: 19295016
[TBL] [Abstract][Full Text] [Related]
5. Soluble N-cadherin in human biological fluids.
Derycke L; De Wever O; Stove V; Vanhoecke B; Delanghe J; Depypere H; Bracke M
Int J Cancer; 2006 Dec; 119(12):2895-900. PubMed ID: 16998833
[TBL] [Abstract][Full Text] [Related]
6. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Hajra KM; Ji X; Fearon ER
Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
[TBL] [Abstract][Full Text] [Related]
7. Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.
Hu QP; Kuang JY; Yang QK; Bian XW; Yu SC
Int J Cancer; 2016 Jun; 138(12):2804-12. PubMed ID: 26704932
[TBL] [Abstract][Full Text] [Related]
8. Soluble fragment of P-cadherin adhesion protein found in human milk.
Soler AP; Russo J; Russo IH; Knudsen KA
J Cell Biochem; 2002; 85(1):180-4. PubMed ID: 11891861
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer.
Liang Z; Sun XY; Xu LC; Fu RZ
Med Sci Monit; 2014 Dec; 20():2776-82. PubMed ID: 25553984
[TBL] [Abstract][Full Text] [Related]
10. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032
[TBL] [Abstract][Full Text] [Related]
11. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells.
Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M
J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012
[TBL] [Abstract][Full Text] [Related]
12. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
[TBL] [Abstract][Full Text] [Related]
13. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the human E-cadherin (CDH1) gene.
Berx G; Becker KF; Höfler H; van Roy F
Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
[TBL] [Abstract][Full Text] [Related]
15. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
[TBL] [Abstract][Full Text] [Related]
16. Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7.
Ye Y; Gao JX; Tian H; Yearsley K; Lange AR; Robertson FM; Barsky SH
Mol Cancer Res; 2012 Jun; 10(6):713-26. PubMed ID: 22638108
[TBL] [Abstract][Full Text] [Related]
17. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.
Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C
J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells.
Nawrocki-Raby B; Gilles C; Polette M; Bruyneel E; Laronze JY; Bonnet N; Foidart JM; Mareel M; Birembaut P
Int J Cancer; 2003 Jul; 105(6):790-5. PubMed ID: 12767064
[TBL] [Abstract][Full Text] [Related]
19. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
Ribeiro AS; Albergaria A; Sousa B; Correia AL; Bracke M; Seruca R; Schmitt FC; Paredes J
Oncogene; 2010 Jan; 29(3):392-402. PubMed ID: 19901964
[TBL] [Abstract][Full Text] [Related]
20. Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP.
Weiss JV; Klein-Scory S; Kübler S; Reinacher-Schick A; Stricker I; Schmiegel W; Schwarte-Waldhoff I
Int J Cancer; 2011 Mar; 128(6):1384-92. PubMed ID: 20473926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
